Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 31 citing articles:

Transcription factor ZNF263 enhances EGFR-targeted therapeutic response and reduces residual disease in lung adenocarcinoma
Jiaqi Liang, Guoshu Bi, Qihai Sui, et al.
Cell Reports (2024) Vol. 43, Iss. 2, pp. 113771-113771
Open Access | Times Cited: 12
Pitfalls and Considerations in Determining the Potency and Mutant Selectivity of Covalent Epidermal Growth Factor Receptor Inhibitors
Kristopher W. Hoyt, Daniel A. Urul, Blessing C. Ogboo, et al.
Journal of Medicinal Chemistry (2023) Vol. 67, Iss. 1, pp. 2-16
Open Access | Times Cited: 15
Targeted dual degradation of HER2 and EGFR obliterates oncogenic signaling, overcomes therapy resistance, and inhibits metastatic lesions in HER2-positive breast cancer models
Lu Yang, Arup Bhattacharya, Darrell L. Peterson, et al.
Drug Resistance Updates (2024) Vol. 74, pp. 101078-101078
Open Access | Times Cited: 5
Targeting PD-1/PD-L1 in tumor immunotherapy: Mechanisms and interactions with host growth regulatory pathways
Songyu Shen, Yihan Hong, Jiajun Huang, et al.
Cytokine & Growth Factor Reviews (2024) Vol. 79, pp. 16-28
Closed Access | Times Cited: 4
Evaluation of efficacy of GCSF in reducing neutropenia among carcinoma patients undergoing anti-cancer chemotherapy. A prospective cohort study
Muhammad Hayat Kakar, Sami Ullah, Amjad Khan, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0315435-e0315435
Open Access
Drug‐Induced Liver Injury Associated With Emerging Cancer Therapies
Piotr Chodup, Sophia L. Samodelov, Michele Visentin, et al.
Liver International (2025) Vol. 45, Iss. 2
Open Access
Synergistic anticancer effects of cisplatin and phenolic aglycones of the aerial part of Rumex dentatus L. in tongue squamous cell carcinoma: insights from network pharmacology and biological verification
Amany E. Ragab, Ghada M. Al‐Ashmawy, Sherin Refat El Afify, et al.
BMC Complementary Medicine and Therapies (2025) Vol. 25, Iss. 1
Open Access
From antibodies to nanobodies: The next frontier in cancer theranostics for solid tumors
Sanjana Mehrotra, Navdeep Kaur, Sukhpreet Kaur, et al.
Advances in protein chemistry and structural biology (2025)
Closed Access
Exploring anti-cancer activities of epidermal growth factor-immobilized polymeric nanoparticles
Shota Yamamoto, Chia-Jung Chang, Masao Kamimura, et al.
Science and Technology of Advanced Materials (2025)
Open Access
Epidermal growth factor-mediated suppression of long noncoding RNA LINC01089 prevents proliferation, migration and invasion of epithelial ovarian cancer
Min Qian, Duanrong Zhu, Lu Yang
Inorganic Chemistry Communications (2025), pp. 114027-114027
Closed Access
Paeonol enhances a recombinant EGFR-targeted fusion protein-drug conjugate induced antitumor efficacy in esophageal cancer
Huaiyu Duan, Yuting Li, Xue Zheng, et al.
Biochemical Pharmacology (2025) Vol. 236, pp. 116856-116856
Closed Access
Investigating the Anticancer Activity of Novel 1,2,4-Oxadiazole-Linked 1,2,3-Triazole Moieties via EGFR/pI3K/mTOR Cascade Down-Regulation
Mohammed Salah Ayoup, Mariam Ghanem, Hamida Abdel‐Hamid, et al.
Polycyclic aromatic compounds (2025), pp. 1-20
Closed Access
Exploring new frontiers in lung cancer treatment: The role of cancer‐associated fibroblasts (CAFs) and EGFR‐TKI resistance
Jiaqi Liang, Yong Hu, Cheng Zhan
Clinical and Translational Discovery (2025) Vol. 5, Iss. 2
Open Access
ShcD adaptor protein drives invasion of triple negative breast cancer cells by aberrant activation of EGFR signaling
Hayley R. Lau, Helene S. Smith, Begüm Alural, et al.
Molecular Oncology (2025)
Open Access
Role of Folate Receptor and CD44 in Targeting of Docetaxel and Paclitaxel Fabricated Conjugates for Efficient Cancer Therapy
Amol Tatode, Pranav Agrawal, Jayshree Taksande, et al.
Journal of Medicine Surgery and Public Health (2024), pp. 100163-100163
Open Access | Times Cited: 4
Emerging targeted therapies in oral oncology: Focus on EGFR inhibition
Vishnu Priya Veeraraghavan, Shikhar Daniel, Arun Kumar Dasari, et al.
Oral Oncology Reports (2024) Vol. 11, pp. 100592-100592
Open Access | Times Cited: 3
IRF5 suppresses metastasis through the regulation of tumor-derived extracellular vesicles and pre-metastatic niche formation
Bailey K Roberts, Dan Iris Li, Carter Somerville, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Structure activity relationship for anticancer activities of spirooxindole derivatives: A comprehensive review
Gandhar Pradhan, Kapil Juvale
Bioorganic Chemistry (2024) Vol. 154, pp. 107975-107975
Closed Access | Times Cited: 1
Lactate-Induced HBEGF Shedding and EGFR Activation: Paving the Way to a New Anticancer Therapeutic Opportunity
Valentina Rossi, Alejandro Hochkoeppler, Marzia Govoni, et al.
(2024)
Open Access | Times Cited: 1
Activin A inhibits the migration of human lung adenocarcinoma A549 cells induced by EGF
Fenglin Zhang, Xueling Cui, Ke Yang, et al.
International Immunopharmacology (2024) Vol. 142, pp. 113170-113170
Closed Access | Times Cited: 1
Unraveling the therapeutic potential of Rutin against osteosarcoma cells: Targeting TNF-α and VEGF signaling pathways
G Gnanamathy, S. Nancy Sheela, Rajanathadurai Jeevitha, et al.
Research Square (Research Square) (2024)
Open Access
TGFβ overcomes FGF-induced transinhibition of EGFR in lens cells to enable fibrotic secondary cataract
Judy K. VanSlyke, Bruce A. Boswell, Linda S. Musil
Molecular Biology of the Cell (2024) Vol. 35, Iss. 6
Open Access
The Importance of Screening for EGFR Mutation in Lung Cancer
Deviana Putri Salsabila, Willy Sandhika
International Journal Of Scientific Advances (2024) Vol. 5, Iss. 2
Open Access
Nuclear Epidermal Growth Factor Receptor (Negfr) in Clinical Treatment: A Systematic Review
Junkan Zhu, Zhiyao Wu, Guangyao Shan, et al.
(2024)
Closed Access
Nanomaterial-Driven Advancements in Early Cancer Detection
Nuha Abeer Khan, Naima Syed, Shabina Quadir, et al.
(2024), pp. 151-182
Closed Access
Page 1 - Next Page

Scroll to top